Search research articles
Contact Us
Filters
Showing results (31-40 of 83) with videos related to
Page
of 9
Sort By:
Life Sciences
|
July 21, 1986
Molecular analysis of urinary AT III related antigen in liver cirrhosis
S Ueshima, T Yamamoto, Y Adachi, et al.
Journal of Clinical and Hospital Pharmacy
|
June 1, 1985
Impurity of thrombin preparations for clinical use
S Ueshima, T Yamamoto, K Okada, et al.
British Journal of Pharmacology
|
October 13, 2000
The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice
H Matsuno, O Kozawa, S Ueshima, et al.
Thrombosis Research
|
October 1, 1992
Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation
H Fukao, S Ueshima, K Okada, et al.
Thrombosis Research
|
October 15, 1994
Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex
K Okada, T Nonaka, H Matsumoto, et al.
Seminars in Thrombosis and Hemostasis
|
July 1, 1991
Plasminogen activator inhibitor in stomach and colorectal carcinomas
H Fukao, N Tanaka, S Ueshima, et al.
Haemostasis
|
January 1, 1987
A hereditary dysfibrinogenemia: fibrinogen Awaji
T Matsuo, S Okuno, T Mukaida, et al.
Thrombosis Research
|
October 15, 1988
Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysis
T Matsuo, Y Chikahira, T Yamada, et al.
Thrombosis Research
|
October 15, 1994
Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin
K Okada, H Yuasa, Y Hagiya, et al.
International Journal of Cancer
|
June 19, 1991
Plasminogen activator inhibitor 1 in human carcinoma tissues
N Tanaka, H Fukao, S Ueshima, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 83) with videos related to
Sort By:
Page
of 9
Life Sciences
|
July 21, 1986
Molecular analysis of urinary AT III related antigen in liver cirrhosis
S Ueshima, T Yamamoto, Y Adachi, et al.
Journal of Clinical and Hospital Pharmacy
|
June 1, 1985
Impurity of thrombin preparations for clinical use
S Ueshima, T Yamamoto, K Okada, et al.
British Journal of Pharmacology
|
October 13, 2000
The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice
H Matsuno, O Kozawa, S Ueshima, et al.
Thrombosis Research
|
October 1, 1992
Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation
H Fukao, S Ueshima, K Okada, et al.
Thrombosis Research
|
October 15, 1994
Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex
K Okada, T Nonaka, H Matsumoto, et al.
Seminars in Thrombosis and Hemostasis
|
July 1, 1991
Plasminogen activator inhibitor in stomach and colorectal carcinomas
H Fukao, N Tanaka, S Ueshima, et al.
Haemostasis
|
January 1, 1987
A hereditary dysfibrinogenemia: fibrinogen Awaji
T Matsuo, S Okuno, T Mukaida, et al.
Thrombosis Research
|
October 15, 1988
Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysis
T Matsuo, Y Chikahira, T Yamada, et al.
Thrombosis Research
|
October 15, 1994
Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin
K Okada, H Yuasa, Y Hagiya, et al.
International Journal of Cancer
|
June 19, 1991
Plasminogen activator inhibitor 1 in human carcinoma tissues
N Tanaka, H Fukao, S Ueshima, et al.
Page
of 9